Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028976 · ClinicalTrials.gov registry record · Phase 3
Obesity, Inflammation and Oxidative Stress
A Phase 3 study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- Phase 3
- Development phase
- 512
- Enrollment target
NCT01028976: Completed Phase 3 study, sponsored by University of California, Berkeley.
NCT01028976 is a Phase 3 study that has completed, run by University of California, Berkeley. The registered enrollment target is 512 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01028976, a Phase 3 study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 512 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not Vitamin C (1000 mg/day) can reduce markers of inflammation, especially C-reactive protein (CRP), in obese persons with baseline CRP greater than 1 mg/dl.
Interventions
- DIETARY_SUPPLEMENT Vitamin C (ascorbic acid)
- DIETARY_SUPPLEMENT Placebo tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 3 |
What the finished NCT01028976 record still lists
NCT01028976 is an interventional study that assigns participants to a tested intervention. The registered 512 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 2 interventions - of which Vitamin C (ascorbic acid) is the first listed.
NCT01028976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01028976 about?
NCT01028976 is a clinical study titled "Obesity, Inflammation and Oxidative Stress". The purpose of this study is to determine whether or not Vitamin C (1000 mg/day) can reduce markers of inflammation, especially C-reactive protein (CRP), in obese persons with baseline CRP greater than 1 mg/dl.
What is the current status of trial NCT01028976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 512 participants. The study started on 2010-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01028976?
The interventions under investigation include: Vitamin C (ascorbic acid) (DIETARY_SUPPLEMENT), Placebo tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01028976?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01028976's enrollment target sits among peer trials
512 728th of 2000 higher than 1,273 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia